The anthracyclines doxorubicin (A) and epirubicin (E) are among the most active agents for breast cancer.
Patrick G. Morris, MSc
Advertisement
Articles by Patrick G. Morris, MSc
Advertisement
Latest Updated Articles
- Anthracyclines Are a Critical Component of Adjuvant Chemotherapy
February 18th 2011
Advertisement
Advertisement
Trending on CancerNetwork
1
Melanoma Vaccine Receives FDA Fast Track Designation
2
Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma
3
NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype
4
Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma
5